Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial ...

One of the timeliest and, some say controversial, topics in clinical cardiac electrophysiology today is the proper role of the implantable cardioverter-defibrillator (ICD) in the treatment of patients ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that a cardiac resynchronization therapy defibrillator and an implantable cardioverter ...

There is a reduction in sudden cardiac death risk among patients with heart failure with reduced ejection fraction with an ICD and recent decompensation.

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...

The REFINE-ICD results highlight the need to find better ways to identify at-risk patients who might benefit, one expert says ...

A wearable automatic defibrillator may be an alternative to an implantable cardiac defibrillator for a small group of patients, say researchers. There are few large, randomized and controlled clinical ...

GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Cardioverter Defibrillators ...

Implantable cardioverter defibrillator (ICD) therapy is used in patients with severe left ventricular systolic dysfunction.  The REFINE-ICD trial investigated whether an ICD could improve survival in ...